High Sierra Technologies, Inc. (HSTI)
USD 0.25
(0.0%)
USD 0.25
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 101.5 Thousand USD | -31.61% |
| 2021 | 148.4 Thousand USD | -11.38% |
| 2020 | 167.46 Thousand USD | 0.73% |
| 2019 | 166.25 Thousand USD | -24.52% |
| 2018 | 220.25 Thousand USD | 688190.63% |
| 2017 | 32.00 USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 286.00 USD | 460.78% |
| 2014 | 51.00 USD | -39.29% |
| 2013 | 84.00 USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 29.00 USD | -91.21% |
| 2009 | 330.00 USD | 4614.29% |
| 2008 | 7.00 USD | -91.67% |
| 2007 | 84.00 USD | -50.88% |
| 2006 | 171.00 USD | 755.0% |
| 2005 | 20.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 81.9 Thousand USD | -19.31% |
| 2023 Q3 | 65.8 Thousand USD | 11.55% |
| 2023 Q2 | 58.99 Thousand USD | -27.98% |
| 2022 FY | 101.5 Thousand USD | -31.61% |
| 2022 Q3 | 109.23 Thousand USD | -17.55% |
| 2022 Q2 | 132.48 Thousand USD | -32.54% |
| 2022 Q1 | 196.38 Thousand USD | 32.33% |
| 2022 Q4 | 101.5 Thousand USD | -7.08% |
| 2021 Q2 | 174.81 Thousand USD | 41.27% |
| 2021 Q3 | 145.98 Thousand USD | -16.49% |
| 2021 Q4 | 148.4 Thousand USD | 1.66% |
| 2021 FY | 148.4 Thousand USD | -11.38% |
| 2021 Q1 | 123.74 Thousand USD | -26.11% |
| 2020 Q3 | 176.52 Thousand USD | 22.87% |
| 2020 FY | 167.46 Thousand USD | 0.73% |
| 2020 Q1 | 152.52 Thousand USD | -8.25% |
| 2020 Q2 | 143.66 Thousand USD | -5.81% |
| 2020 Q4 | 167.46 Thousand USD | -5.13% |
| 2019 Q4 | 166.25 Thousand USD | -60.35% |
| 2019 Q2 | 279.43 Thousand USD | 68.63% |
| 2019 Q1 | 165.7 Thousand USD | -24.77% |
| 2019 Q3 | 419.29 Thousand USD | 50.05% |
| 2019 FY | 166.25 Thousand USD | -24.52% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q4 | 220.25 Thousand USD | 4.28% |
| 2018 FY | 220.25 Thousand USD | 688190.63% |
| 2018 Q2 | 499.97 Thousand USD | 0.0% |
| 2018 Q3 | 211.22 Thousand USD | -57.75% |
| 2017 Q3 | 61.00 USD | -29.07% |
| 2017 FY | 32.00 USD | 0.0% |
| 2017 Q1 | - USD | 100.0% |
| 2017 Q4 | 32.00 USD | -47.54% |
| 2017 Q2 | 86.00 USD | 0.0% |
| 2016 Q3 | 79.00 USD | 54.9% |
| 2016 Q4 | -36.27 Thousand USD | -46020.25% |
| 2016 FY | - USD | -100.0% |
| 2016 Q2 | 51.00 USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2015 Q4 | 286.00 USD | 0.0% |
| 2015 Q1 | - USD | -100.0% |
| 2015 FY | 286.00 USD | 460.78% |
| 2015 Q2 | 4939.00 USD | 0.0% |
| 2015 Q3 | - USD | -100.0% |
| 2014 Q3 | 187.00 USD | 65.49% |
| 2014 Q4 | 51.00 USD | -72.73% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q2 | 113.00 USD | 0.0% |
| 2014 FY | 51.00 USD | -39.29% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 84.00 USD | 0.0% |
| 2013 Q4 | 84.00 USD | -22.94% |
| 2013 Q3 | 109.00 USD | 0.93% |
| 2013 Q2 | 108.00 USD | 0.0% |
| 2012 Q4 | - USD | -100.0% |
| 2012 Q3 | 182.00 USD | -37.46% |
| 2012 Q2 | 291.00 USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q3 | 405.00 USD | 45.68% |
| 2011 Q2 | 278.00 USD | -94.06% |
| 2011 Q1 | 4682.00 USD | 16044.83% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q4 | 29.00 USD | -50.85% |
| 2010 Q3 | 59.00 USD | -29.76% |
| 2010 FY | 29.00 USD | -91.21% |
| 2010 Q2 | 84.00 USD | 0.0% |
| 2009 Q3 | 44.00 USD | -37.14% |
| 2009 FY | 330.00 USD | 4614.29% |
| 2009 Q4 | - USD | -100.0% |
| 2009 Q1 | 94.00 USD | 1242.86% |
| 2009 Q2 | 70.00 USD | -25.53% |
| 2008 Q4 | 7.00 USD | -92.86% |
| 2008 Q2 | 3145.00 USD | 0.0% |
| 2008 Q1 | - USD | -100.0% |
| 2008 FY | 7.00 USD | -91.67% |
| 2008 Q3 | 98.00 USD | -96.88% |
| 2007 Q2 | 776.00 USD | 431.51% |
| 2007 Q4 | 84.00 USD | -88.86% |
| 2007 FY | 84.00 USD | -50.88% |
| 2007 Q1 | 146.00 USD | -14.62% |
| 2007 Q3 | 754.00 USD | -2.84% |
| 2006 Q3 | 195.00 USD | 6400.0% |
| 2006 Q4 | 171.00 USD | -12.31% |
| 2006 FY | 171.00 USD | 755.0% |
| 2006 Q2 | 3.00 USD | 0.0% |
| 2005 FY | 20.00 USD | 0.0% |
| 2005 Q4 | 20.00 USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| BioQuest Corp. | 5914.00 USD | -1616.3% |
| GSRX Industries Inc. | - USD | -Infinity% |
| Instadose Pharma Corp. | - USD | -Infinity% |